Skip to main content

Current Opinion in Immunology

  • ISSN: 0952-7915

Next planned ship date: May 3, 2024

  • 5 Year impact factor: 7
  • Impact factor: 7

Current Opinion in Immunology aims to stimulate scientifically grounded, interdisciplinary, multi-scale debate and exchange of ideas. It contains polished, concise and timely r… Read more

Subscription options

Next planned ship date:
May 3, 2024

Institutional subscription on ScienceDirect

Request a sales quote


Current Opinion in Immunology aims to stimulate scientifically grounded, interdisciplinary, multi-scale debate and exchange of ideas. It contains polished, concise and timely reviews and opinions, with particular emphasis on those articles published in the past two years. In addition to describing recent trends, the authors are encouraged to give their subjective opinion of the topics discussed.


In Current Opinion in Immunology we help the reader by providing in a systematic manner: 1. The views of experts on current advances in their field in a clear and readable form. 2. Evaluations of the most interesting papers, annotated by experts, from the great wealth of original publications.


Current Opinion in Immunology will serve as an invaluable source of information for researchers, lecturers, teachers, professionals, policy makers and students.


Current Opinion in Immunology builds on Elsevier's reputation for excellence in scientific publishing and long-standing commitment to communicating reproducible biomedical research targeted at improving human health. It is a companion to the new Gold Open Access journal Current Research in Immunology and is part of the Current Opinion and Research(CO+RE) suite of journals. All CO+RE journals leverage the Current Opinion legacy-of editorial excellence, high-impact, and global reach-to ensure they are a widely read resource that is integral to scientists' workflow.

Expertise - Editors and Editorial Board bring depth and breadth of expertise and experience to the journal.


Discoverability - Articles get high visibility and maximum exposure on an industry-leading platform that reaches a vast global audience.

Division of the subject into sections
The subject of Immunology is divided into 8 themed sections and 2 special sections, each of which is reviewed once a year.


Innate immunity

Tumour immunology

Lymphocyte development and activation

Antigen processing

Vaccines

Allergy and hypersensitivity

Host pathogens

Autoimmunity



Selection of topics to be reviewed
Section Editors, who are major authorities in the field, are appointed by the Editors of the journal. They divide their section into a number of topics, ensuring that the field is comprehensively covered and that all issues of current importance are emphasised. Section Editors commission reviews from authorities on each topic that they have selected. The Editorial Board provides support to the Editors and the Section Editors with their comments and suggestions on names and topics.
Review articles in Current Opinion in Immunology are by invitation only.


Review Articles
Authors write short review articles in which they present recent developments in their subject, emphasizing the aspects that, in their opinion, are most important. In addition, they provide short annotations to the papers that they consider to be most interesting from all those published in their topic over the previous two years.


Editorial Overview
Section Editors write a short overview at the beginning of the section to introduce the reviews and to draw the reader's attention to any particularly interesting developments. This successful format has made Current Opinion in Immunology one of the most highly regarded and highly cited review journals in the field.